AG真人官方

STOCK TITAN

[SCHEDULE 13G/A] Ironwood Pharmaceuticals, Inc. - SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



The Vanguard Group
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:07/07/2025
Ironwood

NASDAQ:IRWD

IRWD Rankings

IRWD Latest News

IRWD Latest SEC Filings

IRWD Stock Data

145.14M
157.08M
2.68%
98.4%
4.03%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
United States
BOSTON